EUPL 2027 BEGINS IN
- 00Days
- 00Hrs
- 00Mins
- 00Secs
18-20 May 2027
Steigenberger Icon Wiltcher's, Brussels, BE18-20 May 2027
Steigenberger Icon Wiltcher's, Brussels, BE
Steigenberger Icon Wiltcher's, Brussels, BE
Join Dechert at EU Pharmaceutical Law Forum 2024
You're Invited to EU Pharma Law with an Exclusive 10% Off
We are excited to announce that Dechert will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Dechert, we have an exclusive 10% discount* for you. Your VIP discount code is: P24DECHERT
*T&C's Apply
TRI DIALOGUE Regulatory Framework Developments for Artificial Intelligence
- How does the EU MDR and IVDR fit with the AI Act?
- Practical considerations for pharmaceutical companies and device manufacturers
- Update on EMA reflection paper on use of AI in medicinal product lifecycle
- Overlaying European proposals with US frameworks for AI and the implications for global policies
Presented By:
DUAL DIALOGUE Advice on Key Antitrust Hurdles Impacting Commercial Transactions
- Foreign subsidies regulation: what are the obligations?
- Review of recent pharmaceutical merger control cases and authority approach
- Horizontal Block Exemption Regulations and revised Horizontal Guidelines
- Given today’s environment how can you prepare for regulatory scrutiny in commercial transactions?
Presented By:
Opening Remarks from Morning Chair
- Recent developments and global antitrust trends
- Influence of EU antitrust thinking on US approach